Moderna’s Cancer Vaccine Shows Promise | Lubbock News

Moderna’s cancer vaccine, built on mRNA tech like its COVID shots, just sent stocks soaring after early data showed promise—patients on the combo with Merck’s Keytruda lived longer without cancer recurrence. The personalized treatment targets tumor mutations, and full results are coming soon at a medical conference. This could be a game-changer in oncology. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/46858888eba2a1c2